Invention Grant
![Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteins](/docs/US/2019-04-16/US10259809B2/abs.jpg.600x600.jpg)
- Patent Title: Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteins
-
Application No.: US15546324Application Date: 2016-02-03
-
Publication No.: US10259809B2Publication Date: 2019-04-16
- Inventor: Abdelmalik Slassi , Peter Dove
- Applicant: Trillium Therapeutics Inc.
- Applicant Address: CA Toronto
- Assignee: TRILLIUM THERAPEUTICS INC.
- Current Assignee: TRILLIUM THERAPEUTICS INC.
- Current Assignee Address: CA Toronto
- Agency: Bereskin & Parr LLP/S.E.N.C.R.L. s.r.l.
- Agent Patricia Folkins
- International Application: PCT/CA2016/050097 WO 20160203
- International Announcement: WO2016/123709 WO 20160811
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/437 ; A61K31/4745 ; A61K45/06 ; A61K31/496 ; A61K31/5377 ; A61K51/04
![Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteins](/abs-image/US/2019/04/16/US10259809B2/abs.jpg.150x150.jpg)
Abstract:
A novel class of fluorinated derivatives of Formula (I) have been prepared and found to be useful in the treatment of cancers and other disorders related mediated by Bromodomain-Containing Proteins.
Public/Granted literature
- US20180016271A1 FLUORINATED IMIDAZO[4,5-C]QUINOLINE DERIVATIVES AS INHIBITORS OF BROMODOMAIN CONTAINING PROTEINS Public/Granted day:2018-01-18
Information query
